USPTO serial 79205165
DRAINHUNT
Reviewed by CopyMark Law Group
Reg. 5388879Status 709
- Filing date
- Status date
- Registration date
- Jan 30, 2018
- Examiner
- CHANG, ELIZABETH YI HSUAN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with DRAINHUNT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical products for the production of viral, retroviral and non-viral vectors | SECTION 71 - CANCELLED | — |
| 005 | Biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for use in neurodegenerative diseases; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for use in trinucleotide repeat disorders, in particular for use in Huntington's Chorea; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for preventing neurodegenerative diseases; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for preventing trinucleotide repeat disorders, in particular for preventing Huntington's Chorea; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for the treatment of neurodegenerative diseases; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for the treatment of trinucleotide repeat disorders, in particular for the treatment of Huntington'a chorea; biochemical and chemical preparations for medical purposes in oral administration forms, namely, pills, tablets, dragées, capsules, liquids, drops, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of neurodegenerative diseases; biochemical and chemical preparations for medical purposes in oral administration forms, namely, pills, tablets, dragées, capsules, liquids, drops, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of trinucleotide repeat disorders; biochemical and chemical preparations for medical purposes in oral administration forms, namely, pills, tablets, dragées, capsules, liquids, drops, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of Huntington's Chorea; biochemical and chemical preparations for medical purposes in parenteral administration forms, namely, injection solutions and infusion solutions, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of neurodegenerative diseases; biochemical and chemical preparations for medical purposes in parenteral administration forms, namely, injection solutions and infusion solutions, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of trinucleotide repeat disorders; biochemical and chemical preparations for medical purposes in parenteral administration forms, namely, injection solutions and infusion solutions, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of Huntington's chorea | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 8, 2025 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jul 17, 2025 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jul 17, 2025 | INPC | INVALIDATION PROCESSED | — |
| Apr 16, 2025 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Aug 16, 2024 | C71T | CANCELLED SECTION 71 | — |
| Jan 30, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Mar 11, 2022 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Mar 11, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 12, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 8, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 2, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 2, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 30, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 30, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 14, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 14, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 25, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 9, 2017 | ALIE | ASSIGNED TO LIE | — |
| Sep 23, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 20, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 19, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 19, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 19, 2017 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 5, 2017 | RFNP | REFUSAL PROCESSED BY IB | — |
| Apr 19, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 19, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 19, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 16, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 15, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 15, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 15, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 13, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |